相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease
Matthew J. Simon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes
Naoki Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation
Wen-Han Cheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer
Lijun Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes
Naoki Yamamoto et al.
NEUROSCIENCE LETTERS (2013)
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain
D. Allan Butterfield et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease
Eugenio Barone et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Reactive astrocytes give neurons less support: implications for Alzheimer's disease
Megan L. Steele et al.
NEUROBIOLOGY OF AGING (2012)
Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders
D. Allan Butterfield et al.
PHARMACOLOGICAL RESEARCH (2011)
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: A novel mechanism of action
Eugenio Barone et al.
PHARMACOLOGICAL RESEARCH (2011)
Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain
Suqing Wang et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons
Jian Zou et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Astrocytes as gate-keepers in optic nerve regeneration - A mini-review
Dana M. Garcia et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY (2009)
Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
Ian J. Martins et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests
K. A. Bates et al.
MOLECULAR PSYCHIATRY (2009)
NEUROSCIENCE Alzheimer's disease
Lennart Mucke
NATURE (2009)
Neprilysin: An enzyme candidate to slow the progression of Alzheimer's disease
Salim S. El-Amouri et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
Transplanted Astrocytes internalize deposited β-amyloid peptides in a transgenic mouse model of Alzheimer's disease
Rea Pihlaja et al.
GLIA (2008)
Regulation of the lipidation of β-secretase by statins
R. B. Parsons et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Statins induce differentiation and cell death in neurons and astroglia
Pia Maerz et al.
GLIA (2007)
Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic Tg2576 mice with Alzheimer pathology
Maria C. Leal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Omega-3 fatty acids, energy substrates, and brain function during aging
Erika Freemantle et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Astrocyte dysfunction in neurological disorders:: a molecular perspective
G Seifert et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-β peptide-induced cerebrovascular endothelial cell death
KJ Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
The involvement of lipid rafts in Alzheimer's disease (Review)
JM Cordy et al.
MOLECULAR MEMBRANE BIOLOGY (2006)
Age- and region-dependent alterations in Aβ-degrading enzymes:: implications for Aβ-induced disorders
A Caccamo et al.
NEUROBIOLOGY OF AGING (2005)
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
M Koistinaho et al.
NATURE MEDICINE (2004)
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
T Wyss-Coray et al.
NATURE MEDICINE (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Aging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques
J Apelt et al.
NEUROSCIENCE LETTERS (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Differential regulation of aquaporin-5 and-9 expression in astrocytes by protein kinase A
N Yamamoto et al.
MOLECULAR BRAIN RESEARCH (2002)
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people
K Rockwood et al.
ARCHIVES OF NEUROLOGY (2002)
Serum lipoprotein levels, statin use, and cognitive function in older women
K Yaffe et al.
ARCHIVES OF NEUROLOGY (2002)
A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease
LM Refolo et al.
NEUROBIOLOGY OF DISEASE (2001)
Metabolic regulation of brain Aβ by neprilysin
N Iwata et al.
SCIENCE (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
B Wolozin et al.
ARCHIVES OF NEUROLOGY (2000)
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
LM Refolo et al.
NEUROBIOLOGY OF DISEASE (2000)
分享论文
